Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineering epidermal growth factor for enhanced mitogenic potency

C C Reddy1, S K Niyogi, A Wells

  • 1Department of Chemical Engineering, University of Illinois at Urbana-Champaign 61801, USA.

Nature Biotechnology
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective deep lobe parotidectomy: a systematic review and meta-analysis of outcomes.

The British journal of oral & maxillofacial surgery·2026
Same author

Evolution of a Client-Level Dataset: 20 Years of National Child Traumatic Stress Network Data Collection.

International journal of methods in psychiatric research·2026
Same author

Individual- and Neighborhood-Level Predictors of HIV Care Continuum Progression: Clark County, Nevada.

Open forum infectious diseases·2025
Same author

A core outcome set for cranioplasty following stroke or traumatic brain injury - The COAST study.

Brain & spine·2025
Same author

Towards Consensus: A Pilot Study in Enhancing Recognition of Equine Affective States with RaiSE (Recognizing Affective States in Equine).

Journal of applied animal welfare science : JAAWS·2025
Same author

New and Interesting Fungi. 5.

Fungal systematics and evolution·2023
Same journal

Author Correction: Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy.

Nature biotechnology·2026
Same journal

Quantum computing in transition.

Nature biotechnology·2026
Same journal

Author Correction: Improved RNA base editing with guide RNAs mimicking highly edited endogenous ADAR substrates.

Nature biotechnology·2026
Same journal

Unlocking the chemical potential of filamentous fungi using prime editing.

Nature biotechnology·2026
Same journal

A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

Nature biotechnology·2026
Same journal

Prime editing for precise genome engineering and modulation of fungal metabolism.

Nature biotechnology·2026
See all related articles

Researchers developed a novel epidermal growth factor (EGF) mutant that enhances fibroblast proliferation by altering receptor trafficking. This breakthrough offers a more effective therapeutic strategy than current methods for growth factor applications.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Biotechnology

Background:

  • Therapeutic and bioprocessing applications of growth factors face challenges like depletion and receptor down-regulation.
  • Existing methods involve high concentrations or complex delivery systems, which are often physiologically inappropriate.

Purpose of the Study:

  • To investigate ligand/receptor trafficking processes to overcome growth factor attenuation mechanisms.
  • To develop a novel growth factor mutant with improved therapeutic potential.

Main Methods:

  • Engineered a recombinant epidermal growth factor (EGF) mutant with reduced receptor binding affinity.
  • Assessed the mitogenic stimulus for fibroblasts compared to natural EGF and transforming growth factor alpha.

Main Results:

Related Experiment Videos

  • The EGF mutant demonstrated superior potency as a mitogenic stimulus for fibroblasts.
  • This enhanced efficacy is attributed to the mutant's altered receptor trafficking properties.
  • The mutant overcomes typical attenuation mechanisms more effectively than natural ligands.

Conclusions:

  • Altering ligand/receptor trafficking offers a new paradigm for designing potent growth factors.
  • This strategy provides a more physiologically appropriate method for enhancing growth factor efficacy in therapeutic and bioprocessing applications.
  • The developed EGF mutant shows promise for improved fibroblast stimulation and wound healing applications.